Targeting MET by tyrosine kinase inhibitor suppresses growth and invasion of nasopharyngeal carcinoma cell lines.
about
MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic targetCelastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo.
P2860
Targeting MET by tyrosine kinase inhibitor suppresses growth and invasion of nasopharyngeal carcinoma cell lines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@en
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@nl
type
label
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@en
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@nl
prefLabel
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@en
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@nl
P2860
P1476
Targeting MET by tyrosine kina ...... aryngeal carcinoma cell lines.
@en
P2093
Elaine Y Wong
Patrick C Lau
P2860
P2888
P304
P356
10.1007/S12253-011-9452-1
P577
2011-08-25T00:00:00Z